Total: £ 56.28
Published Date: 2024-09-13 | Pages: 156 | Tables: 231 | Medical Care
The global market for Cold Chain for Pharmaceutical was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cold Chain for Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cold Chain for Pharmaceutical by region & country, by Type, and by Application.
The Cold Chain for Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold Chain for Pharmaceutical.
Market Segmentation
By Company
Deutsche Post
FedEx
Biotec Services
UPS
Nichirei Logistics Group
Air Canada Cargo
Helapet
Igloo Thermo-Logistics
Kerry Logistics
XPO Logistics
Cold Chain Technologies
Continental Air Cargo
Lineage Logistics
OOCL Logistics
SCG Logistics
JWD Group
Swire Group
Burris Logistics
VersaCold Logistics Services
LifeConEx
Marken
Nordic Cold Storage
Panalpina World Transport
Sofrigam
Segment by Type:
Refrigerated Storage
Cold Chain Logistics
Segment by Application
Pharmaceuticals
Blood Goods
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cold Chain for Pharmaceutical manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cold Chain for Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cold Chain for Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Cold Chain for Pharmaceutical Product Introduction
1.2 Global Cold Chain for Pharmaceutical Market Size Forecast
1.3 Cold Chain for Pharmaceutical Market Trends & Drivers
1.3.1 Cold Chain for Pharmaceutical Industry Trends
1.3.2 Cold Chain for Pharmaceutical Market Drivers & Opportunity
1.3.3 Cold Chain for Pharmaceutical Market Challenges
1.3.4 Cold Chain for Pharmaceutical Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cold Chain for Pharmaceutical Players Revenue Ranking (2023)
2.2 Global Cold Chain for Pharmaceutical Revenue by Company (2019-2024)
2.3 Key Companies Cold Chain for Pharmaceutical Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cold Chain for Pharmaceutical Product Offered
2.5 Key Companies Time to Begin Mass Production of Cold Chain for Pharmaceutical
2.6 Cold Chain for Pharmaceutical Market Competitive Analysis
2.6.1 Cold Chain for Pharmaceutical Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cold Chain for Pharmaceutical Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Chain for Pharmaceutical as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Refrigerated Storage
3.1.2 Cold Chain Logistics
3.2 Global Cold Chain for Pharmaceutical Sales Value by Type
3.2.1 Global Cold Chain for Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cold Chain for Pharmaceutical Sales Value, by Type (2019-2030)
3.2.3 Global Cold Chain for Pharmaceutical Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceuticals
4.1.2 Blood Goods
4.1.3 Other
4.2 Global Cold Chain for Pharmaceutical Sales Value by Application
4.2.1 Global Cold Chain for Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cold Chain for Pharmaceutical Sales Value, by Application (2019-2030)
4.2.3 Global Cold Chain for Pharmaceutical Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cold Chain for Pharmaceutical Sales Value by Region
5.1.1 Global Cold Chain for Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cold Chain for Pharmaceutical Sales Value by Region (2019-2024)
5.1.3 Global Cold Chain for Pharmaceutical Sales Value by Region (2025-2030)
5.1.4 Global Cold Chain for Pharmaceutical Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cold Chain for Pharmaceutical Sales Value, 2019-2030
5.2.2 North America Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cold Chain for Pharmaceutical Sales Value, 2019-2030
5.3.2 Europe Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cold Chain for Pharmaceutical Sales Value, 2019-2030
5.4.2 Asia Pacific Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cold Chain for Pharmaceutical Sales Value, 2019-2030
5.5.2 South America Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cold Chain for Pharmaceutical Sales Value, 2019-2030
5.6.2 Middle East & Africa Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cold Chain for Pharmaceutical Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cold Chain for Pharmaceutical Sales Value
6.3 United States
6.3.1 United States Cold Chain for Pharmaceutical Sales Value, 2019-2030
6.3.2 United States Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cold Chain for Pharmaceutical Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cold Chain for Pharmaceutical Sales Value, 2019-2030
6.4.2 Europe Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cold Chain for Pharmaceutical Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cold Chain for Pharmaceutical Sales Value, 2019-2030
6.5.2 China Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cold Chain for Pharmaceutical Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cold Chain for Pharmaceutical Sales Value, 2019-2030
6.6.2 Japan Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cold Chain for Pharmaceutical Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cold Chain for Pharmaceutical Sales Value, 2019-2030
6.7.2 South Korea Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cold Chain for Pharmaceutical Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cold Chain for Pharmaceutical Sales Value, 2019-2030
6.8.2 Southeast Asia Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cold Chain for Pharmaceutical Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cold Chain for Pharmaceutical Sales Value, 2019-2030
6.9.2 India Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cold Chain for Pharmaceutical Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Deutsche Post
7.1.1 Deutsche Post Profile
7.1.2 Deutsche Post Main Business
7.1.3 Deutsche Post Cold Chain for Pharmaceutical Products, Services and Solutions
7.1.4 Deutsche Post Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.1.5 Deutsche Post Recent Developments
7.2 FedEx
7.2.1 FedEx Profile
7.2.2 FedEx Main Business
7.2.3 FedEx Cold Chain for Pharmaceutical Products, Services and Solutions
7.2.4 FedEx Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.2.5 FedEx Recent Developments
7.3 Biotec Services
7.3.1 Biotec Services Profile
7.3.2 Biotec Services Main Business
7.3.3 Biotec Services Cold Chain for Pharmaceutical Products, Services and Solutions
7.3.4 Biotec Services Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.3.5 UPS Recent Developments
7.4 UPS
7.4.1 UPS Profile
7.4.2 UPS Main Business
7.4.3 UPS Cold Chain for Pharmaceutical Products, Services and Solutions
7.4.4 UPS Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.4.5 UPS Recent Developments
7.5 Nichirei Logistics Group
7.5.1 Nichirei Logistics Group Profile
7.5.2 Nichirei Logistics Group Main Business
7.5.3 Nichirei Logistics Group Cold Chain for Pharmaceutical Products, Services and Solutions
7.5.4 Nichirei Logistics Group Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.5.5 Nichirei Logistics Group Recent Developments
7.6 Air Canada Cargo
7.6.1 Air Canada Cargo Profile
7.6.2 Air Canada Cargo Main Business
7.6.3 Air Canada Cargo Cold Chain for Pharmaceutical Products, Services and Solutions
7.6.4 Air Canada Cargo Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.6.5 Air Canada Cargo Recent Developments
7.7 Helapet
7.7.1 Helapet Profile
7.7.2 Helapet Main Business
7.7.3 Helapet Cold Chain for Pharmaceutical Products, Services and Solutions
7.7.4 Helapet Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.7.5 Helapet Recent Developments
7.8 Igloo Thermo-Logistics
7.8.1 Igloo Thermo-Logistics Profile
7.8.2 Igloo Thermo-Logistics Main Business
7.8.3 Igloo Thermo-Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
7.8.4 Igloo Thermo-Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.8.5 Igloo Thermo-Logistics Recent Developments
7.9 Kerry Logistics
7.9.1 Kerry Logistics Profile
7.9.2 Kerry Logistics Main Business
7.9.3 Kerry Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
7.9.4 Kerry Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.9.5 Kerry Logistics Recent Developments
7.10 XPO Logistics
7.10.1 XPO Logistics Profile
7.10.2 XPO Logistics Main Business
7.10.3 XPO Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
7.10.4 XPO Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.10.5 XPO Logistics Recent Developments
7.11 Cold Chain Technologies
7.11.1 Cold Chain Technologies Profile
7.11.2 Cold Chain Technologies Main Business
7.11.3 Cold Chain Technologies Cold Chain for Pharmaceutical Products, Services and Solutions
7.11.4 Cold Chain Technologies Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.11.5 Cold Chain Technologies Recent Developments
7.12 Continental Air Cargo
7.12.1 Continental Air Cargo Profile
7.12.2 Continental Air Cargo Main Business
7.12.3 Continental Air Cargo Cold Chain for Pharmaceutical Products, Services and Solutions
7.12.4 Continental Air Cargo Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.12.5 Continental Air Cargo Recent Developments
7.13 Lineage Logistics
7.13.1 Lineage Logistics Profile
7.13.2 Lineage Logistics Main Business
7.13.3 Lineage Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
7.13.4 Lineage Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.13.5 Lineage Logistics Recent Developments
7.14 OOCL Logistics
7.14.1 OOCL Logistics Profile
7.14.2 OOCL Logistics Main Business
7.14.3 OOCL Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
7.14.4 OOCL Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.14.5 OOCL Logistics Recent Developments
7.15 SCG Logistics
7.15.1 SCG Logistics Profile
7.15.2 SCG Logistics Main Business
7.15.3 SCG Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
7.15.4 SCG Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.15.5 SCG Logistics Recent Developments
7.16 JWD Group
7.16.1 JWD Group Profile
7.16.2 JWD Group Main Business
7.16.3 JWD Group Cold Chain for Pharmaceutical Products, Services and Solutions
7.16.4 JWD Group Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.16.5 JWD Group Recent Developments
7.17 Swire Group
7.17.1 Swire Group Profile
7.17.2 Swire Group Main Business
7.17.3 Swire Group Cold Chain for Pharmaceutical Products, Services and Solutions
7.17.4 Swire Group Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.17.5 Swire Group Recent Developments
7.18 Burris Logistics
7.18.1 Burris Logistics Profile
7.18.2 Burris Logistics Main Business
7.18.3 Burris Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
7.18.4 Burris Logistics Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.18.5 Burris Logistics Recent Developments
7.19 VersaCold Logistics Services
7.19.1 VersaCold Logistics Services Profile
7.19.2 VersaCold Logistics Services Main Business
7.19.3 VersaCold Logistics Services Cold Chain for Pharmaceutical Products, Services and Solutions
7.19.4 VersaCold Logistics Services Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.19.5 VersaCold Logistics Services Recent Developments
7.20 LifeConEx
7.20.1 LifeConEx Profile
7.20.2 LifeConEx Main Business
7.20.3 LifeConEx Cold Chain for Pharmaceutical Products, Services and Solutions
7.20.4 LifeConEx Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.20.5 LifeConEx Recent Developments
7.21 Marken
7.21.1 Marken Profile
7.21.2 Marken Main Business
7.21.3 Marken Cold Chain for Pharmaceutical Products, Services and Solutions
7.21.4 Marken Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.21.5 Marken Recent Developments
7.22 Nordic Cold Storage
7.22.1 Nordic Cold Storage Profile
7.22.2 Nordic Cold Storage Main Business
7.22.3 Nordic Cold Storage Cold Chain for Pharmaceutical Products, Services and Solutions
7.22.4 Nordic Cold Storage Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.22.5 Nordic Cold Storage Recent Developments
7.23 Panalpina World Transport
7.23.1 Panalpina World Transport Profile
7.23.2 Panalpina World Transport Main Business
7.23.3 Panalpina World Transport Cold Chain for Pharmaceutical Products, Services and Solutions
7.23.4 Panalpina World Transport Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.23.5 Panalpina World Transport Recent Developments
7.24 Sofrigam
7.24.1 Sofrigam Profile
7.24.2 Sofrigam Main Business
7.24.3 Sofrigam Cold Chain for Pharmaceutical Products, Services and Solutions
7.24.4 Sofrigam Cold Chain for Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.24.5 Sofrigam Recent Developments
8 Industry Chain Analysis
8.1 Cold Chain for Pharmaceutical Industrial Chain
8.2 Cold Chain for Pharmaceutical Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cold Chain for Pharmaceutical Sales Model
8.5.2 Sales Channel
8.5.3 Cold Chain for Pharmaceutical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Cold Chain for Pharmaceutical Market Trends
Table 2. Cold Chain for Pharmaceutical Market Drivers & Opportunity
Table 3. Cold Chain for Pharmaceutical Market Challenges
Table 4. Cold Chain for Pharmaceutical Market Restraints
Table 5. Global Cold Chain for Pharmaceutical Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cold Chain for Pharmaceutical Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cold Chain for Pharmaceutical Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cold Chain for Pharmaceutical Product Type
Table 9. Key Companies Time to Begin Mass Production of Cold Chain for Pharmaceutical
Table 10. Global Cold Chain for Pharmaceutical Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Chain for Pharmaceutical as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cold Chain for Pharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cold Chain for Pharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cold Chain for Pharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cold Chain for Pharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cold Chain for Pharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cold Chain for Pharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cold Chain for Pharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cold Chain for Pharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cold Chain for Pharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cold Chain for Pharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cold Chain for Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cold Chain for Pharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cold Chain for Pharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cold Chain for Pharmaceutical Sales Value by Region (2019-2024) & (%)
Table 27. Global Cold Chain for Pharmaceutical Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cold Chain for Pharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cold Chain for Pharmaceutical Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cold Chain for Pharmaceutical Sales Value, (2025-2030) & (US$ Million)
Table 31. Deutsche Post Basic Information List
Table 32. Deutsche Post Description and Business Overview
Table 33. Deutsche Post Cold Chain for Pharmaceutical Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Deutsche Post (2019-2024)
Table 35. Deutsche Post Recent Developments
Table 36. FedEx Basic Information List
Table 37. FedEx Description and Business Overview
Table 38. FedEx Cold Chain for Pharmaceutical Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of FedEx (2019-2024)
Table 40. FedEx Recent Developments
Table 41. Biotec Services Basic Information List
Table 42. Biotec Services Description and Business Overview
Table 43. Biotec Services Cold Chain for Pharmaceutical Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Biotec Services (2019-2024)
Table 45. Biotec Services Recent Developments
Table 46. UPS Basic Information List
Table 47. UPS Description and Business Overview
Table 48. UPS Cold Chain for Pharmaceutical Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of UPS (2019-2024)
Table 50. UPS Recent Developments
Table 51. Nichirei Logistics Group Basic Information List
Table 52. Nichirei Logistics Group Description and Business Overview
Table 53. Nichirei Logistics Group Cold Chain for Pharmaceutical Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Nichirei Logistics Group (2019-2024)
Table 55. Nichirei Logistics Group Recent Developments
Table 56. Air Canada Cargo Basic Information List
Table 57. Air Canada Cargo Description and Business Overview
Table 58. Air Canada Cargo Cold Chain for Pharmaceutical Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Air Canada Cargo (2019-2024)
Table 60. Air Canada Cargo Recent Developments
Table 61. Helapet Basic Information List
Table 62. Helapet Description and Business Overview
Table 63. Helapet Cold Chain for Pharmaceutical Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Helapet (2019-2024)
Table 65. Helapet Recent Developments
Table 66. Igloo Thermo-Logistics Basic Information List
Table 67. Igloo Thermo-Logistics Description and Business Overview
Table 68. Igloo Thermo-Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Igloo Thermo-Logistics (2019-2024)
Table 70. Igloo Thermo-Logistics Recent Developments
Table 71. Kerry Logistics Basic Information List
Table 72. Kerry Logistics Description and Business Overview
Table 73. Kerry Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Kerry Logistics (2019-2024)
Table 75. Kerry Logistics Recent Developments
Table 76. XPO Logistics Basic Information List
Table 77. XPO Logistics Description and Business Overview
Table 78. XPO Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of XPO Logistics (2019-2024)
Table 80. XPO Logistics Recent Developments
Table 81. Cold Chain Technologies Basic Information List
Table 82. Cold Chain Technologies Description and Business Overview
Table 83. Cold Chain Technologies Cold Chain for Pharmaceutical Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Cold Chain Technologies (2019-2024)
Table 85. Cold Chain Technologies Recent Developments
Table 86. Continental Air Cargo Basic Information List
Table 87. Continental Air Cargo Description and Business Overview
Table 88. Continental Air Cargo Cold Chain for Pharmaceutical Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Continental Air Cargo (2019-2024)
Table 90. Continental Air Cargo Recent Developments
Table 91. Lineage Logistics Basic Information List
Table 92. Lineage Logistics Description and Business Overview
Table 93. Lineage Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Lineage Logistics (2019-2024)
Table 95. Lineage Logistics Recent Developments
Table 96. OOCL Logistics Basic Information List
Table 97. OOCL Logistics Description and Business Overview
Table 98. OOCL Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of OOCL Logistics (2019-2024)
Table 100. OOCL Logistics Recent Developments
Table 101. SCG Logistics Basic Information List
Table 102. SCG Logistics Description and Business Overview
Table 103. SCG Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of SCG Logistics (2019-2024)
Table 105. SCG Logistics Recent Developments
Table 106. JWD Group Basic Information List
Table 107. JWD Group Description and Business Overview
Table 108. JWD Group Cold Chain for Pharmaceutical Products, Services and Solutions
Table 109. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of JWD Group (2019-2024)
Table 110. JWD Group Recent Developments
Table 111. Swire Group Basic Information List
Table 112. Swire Group Description and Business Overview
Table 113. Swire Group Cold Chain for Pharmaceutical Products, Services and Solutions
Table 114. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Swire Group (2019-2024)
Table 115. Swire Group Recent Developments
Table 116. Burris Logistics Basic Information List
Table 117. Burris Logistics Description and Business Overview
Table 118. Burris Logistics Cold Chain for Pharmaceutical Products, Services and Solutions
Table 119. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Burris Logistics (2019-2024)
Table 120. Burris Logistics Recent Developments
Table 121. VersaCold Logistics Services Basic Information List
Table 122. VersaCold Logistics Services Description and Business Overview
Table 123. VersaCold Logistics Services Cold Chain for Pharmaceutical Products, Services and Solutions
Table 124. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of VersaCold Logistics Services (2019-2024)
Table 125. VersaCold Logistics Services Recent Developments
Table 126. LifeConEx Basic Information List
Table 127. LifeConEx Description and Business Overview
Table 128. LifeConEx Cold Chain for Pharmaceutical Products, Services and Solutions
Table 129. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of LifeConEx (2019-2024)
Table 130. LifeConEx Recent Developments
Table 131. Marken Basic Information List
Table 132. Marken Description and Business Overview
Table 133. Marken Cold Chain for Pharmaceutical Products, Services and Solutions
Table 134. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Marken (2019-2024)
Table 135. Marken Recent Developments
Table 136. Nordic Cold Storage Basic Information List
Table 137. Nordic Cold Storage Description and Business Overview
Table 138. Nordic Cold Storage Cold Chain for Pharmaceutical Products, Services and Solutions
Table 139. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Nordic Cold Storage (2019-2024)
Table 140. Nordic Cold Storage Recent Developments
Table 141. Panalpina World Transport Basic Information List
Table 142. Panalpina World Transport Description and Business Overview
Table 143. Panalpina World Transport Cold Chain for Pharmaceutical Products, Services and Solutions
Table 144. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Panalpina World Transport (2019-2024)
Table 145. Panalpina World Transport Recent Developments
Table 146. Sofrigam Basic Information List
Table 147. Sofrigam Description and Business Overview
Table 148. Sofrigam Cold Chain for Pharmaceutical Products, Services and Solutions
Table 149. Revenue (US$ Million) in Cold Chain for Pharmaceutical Business of Sofrigam (2019-2024)
Table 150. Sofrigam Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Cold Chain for Pharmaceutical Downstream Customers
Table 154. Cold Chain for Pharmaceutical Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cold Chain for Pharmaceutical Product Picture
Figure 2. Global Cold Chain for Pharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cold Chain for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 4. Cold Chain for Pharmaceutical Report Years Considered
Figure 5. Global Cold Chain for Pharmaceutical Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cold Chain for Pharmaceutical Revenue in 2023
Figure 7. Cold Chain for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Refrigerated Storage Picture
Figure 9. Cold Chain Logistics Picture
Figure 10. Global Cold Chain for Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Cold Chain for Pharmaceutical Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Pharmaceuticals
Figure 13. Product Picture of Blood Goods
Figure 14. Product Picture of Other
Figure 15. Global Cold Chain for Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Cold Chain for Pharmaceutical Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Cold Chain for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Cold Chain for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Cold Chain for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Cold Chain for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Cold Chain for Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Cold Chain for Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Cold Chain for Pharmaceutical Sales Value (%), (2019-2030)
Figure 28. United States Cold Chain for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Cold Chain for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Cold Chain for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Cold Chain for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 34. China Cold Chain for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 36. China Cold Chain for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Cold Chain for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Cold Chain for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Cold Chain for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Cold Chain for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Cold Chain for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Cold Chain for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 46. India Cold Chain for Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Cold Chain for Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 48. India Cold Chain for Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 49. Cold Chain for Pharmaceutical Industrial Chain
Figure 50. Cold Chain for Pharmaceutical Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation